Vanguard Group’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-278,220
| Closed | -$52.3K | – | 4485 |
|
|
2024
Q1 | $52.3K | Sell |
278,220
-7,864
| -3% | -$1.55K | ﹤0.01% | 4315 |
|
|
2023
Q4 | $57.8K | Sell |
286,084
-854,622
| -75% | -$335K | ﹤0.01% | 4358 |
|
|
2023
Q3 | $795K | Hold |
1,140,706
| – | – | ﹤0.01% | 3914 |
|
|
2023
Q2 | $1.01M | Hold |
1,140,706
| – | – | ﹤0.01% | 3896 |
|
|
2023
Q1 | $860K | Hold |
1,140,706
| – | – | ﹤0.01% | 3968 |
|
|
2022
Q4 | $1.31M | Sell |
1,140,706
-1,464
| -0.1% | -$1.21K | ﹤0.01% | 3815 |
|
|
2022
Q3 | $1M | Buy |
1,142,170
+470,719
| +70% | +$570K | ﹤0.01% | 3995 |
|
|
2022
Q2 | $752K | Sell |
671,451
-15,166
| -2% | -$13K | ﹤0.01% | 4178 |
|
|
2022
Q1 | $954K | Sell |
686,617
-347,559
| -34% | -$743K | ﹤0.01% | 4224 |
|
|
2021
Q4 | $3.53M | Buy |
1,034,176
+48,082
| +5% | +$271K | ﹤0.01% | 3799 |
|
|
2021
Q3 | $8.72M | Buy |
986,094
+325,488
| +49% | +$4.28M | ﹤0.01% | 3327 |
|
|
2021
Q2 | $11.2M | Buy |
660,606
+46,118
| +8% | +$675K | ﹤0.01% | 3141 |
|
|
2021
Q1 | $8.22M | Buy |
614,488
+189,366
| +45% | +$4.26M | ﹤0.01% | 3260 |
|
|
2020
Q4 | $12.2M | Buy |
425,122
+24,081
| +6% | +$652K | ﹤0.01% | 2888 |
|
|
2020
Q3 | $11.9M | Buy |
+401,041
| New | +$12.2M | ﹤0.01% | 2703 |
|
Other funds holding AFIB
Vanguard Group's AFIB Position: Q2 2024 in Review
Vanguard Group sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 278,220 shares — an estimated $52.3K sold.
Vanguard Group first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $12.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.
- Vanguard Group reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
- Vanguard Group sold 278,220 Acutus Medical Inc shares in Q2 2024, an estimated $52.3K.
- Vanguard Group first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
- Vanguard Group's Acutus Medical Inc position peaked at $12.2M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.
Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.